Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antipsychotic Switching for People With Schizophrenia Who Have Neuroleptic‐induced Weight or Metabolic Problems." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433999/2/Cognitive_behaviour_therapy_versus_other_psychosocial_treatments_for_schizophrenia:_Cochrane_systematic_review. Accessed 04 October 2023.
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433999/2/Cognitive_behaviour_therapy_versus_other_psychosocial_treatments_for_schizophrenia:_Cochrane_systematic_review. Accessed October 4, 2023.
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433999/2/Cognitive_behaviour_therapy_versus_other_psychosocial_treatments_for_schizophrenia:_Cochrane_systematic_review
Antipsychotic Switching for People With Schizophrenia Who Have Neuroleptic‐induced Weight or Metabolic Problems [Internet]. In: Cochrane Abstracts. [cited 2023 October 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433999/2/Cognitive_behaviour_therapy_versus_other_psychosocial_treatments_for_schizophrenia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
ID - 433999
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433999/2/Cognitive_behaviour_therapy_versus_other_psychosocial_treatments_for_schizophrenia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -